A Comparative Study of Aminosidine Sulfate, Meglomine Antimoniate, Combination of both and Glucantime in Murine Leishmaniasis Treatment of Cutaneous Leishmaniasis, Caused by Leishmania tropica, with Topical Application of Paromomycin 20% in BALB-c Mice
Authors
Abstract
The current treatment of choice for cutaneous leishmaniasis is either parenteral or intralesional antimonial compounds. Each of these treatments has its own downfalls which include toxic side effects with the parentral injection and pain at the site of injection with the intralesional injection. In recent years, there has been more focus on Paromomycin as an alternative drug; however, current data arose many controversies.
In this study, the efficacy of different therapeutic regimens including topical paromomycin 20%, topical gentamycin 0.5%, intralesional glucantime injections, topical paromomycin 20% combine with gentamycin 0.5%, and placebo were compared. The results showed that the topical application of paromomycin had better response, less recurrence. In conclusion, topical paromomycin 20% can be an appropriate substitute for intralesional injection of glucantime, but more studies are needed to support its efficacy in human cutaneous leishmaniasis.
Highlights
Copyright
© 2022, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Intralesional injections of metronidazole versus meglumine antimoniate for the treatment of cutaneous leishmaniasis
Mapar MA, Omidian M, . Intralesional injections of metronidazole versus meglumine antimoniate for the treatment of cutaneous leishmaniasis. Jundishapur J Microbiol. 2010;3(2):. doi:
Therapeutic and Adverse Effects of Glucantime Used for Treatment of Cutaneous Leishmaniasis.
Beheshti M. Therapeutic and Adverse Effects of Glucantime Used for Treatment of Cutaneous Leishmaniasis.. Shiraz E-Med J. 2007;8(4):. doi:
Effect of topical Nanoliposomes of Paromomycin on Rats Liver and Kidney
Kalantari H, Hemmati AA, Bavarsad N, Rezaie A, Ahmadi S. Effect of topical Nanoliposomes of Paromomycin on Rats Liver and Kidney. Jundishapur J Nat Pharm Prod. 2014;9(4):e17565. doi: https://doi.org/10.17795/jjnpp-17565
Comparison Between Intralesional Meglumine Antimoniate and Combination of Trichloroacetic Acid 50% and Intralesional Meglumine Antimoniate in the Treatment of Acute Cutaneous Leishmaniasis: A Randomized Clinical Trial
Nilforoushzadeh MA, Jaffary F, Derakhshan R, Haftbaradaran E. Comparison Between Intralesional Meglumine Antimoniate and Combination of Trichloroacetic Acid 50% and Intralesional Meglumine Antimoniate in the Treatment of Acute Cutaneous Leishmaniasis: A Randomized Clinical Trial. J Skin Stem Cell. 2014;1(1):e16633. doi: https://doi.org/10.17795/jssc16633
Effect of Adjunctive Topical Liposomal Azithromycin on Systemic Azithromycin on Old World Cutaneous Leishmaniasis: A Pilot Clinical Study
Abtahi-Naeini B, Hadian S, Sokhanvari F, Hariri A, Varshosaz J, et al. Effect of Adjunctive Topical Liposomal Azithromycin on Systemic Azithromycin on Old World Cutaneous Leishmaniasis: A Pilot Clinical Study. Iran J Pharm Res. 2021;20(2):e124526. doi: https://doi.org/10.22037/ijpr.2020.113710.14445
- Scopus by DOI: 0
Last Update: 3 weeks ago
- Scopus by Title: 1
Last Update: 3 weeks ago
- Scopus by Title (Ref): 0
Last Update: 3 weeks ago
- CrossRef: 0
Last Update: 6 days ago
- OpenAlex: 0
Last Update: 6 hours ago
- OpenCitations: 0
Last Update: 4 days ago